Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients

Last updated: May 4, 2017

CMS Measure ID: CMS129v4
Version: 4
NQF Number: 0389
Measure Description:

Percentage of patients, regardless of age, with a diagnosis of prostate cancer at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy who did not have a bone scan performed at any time since diagnosis of prostate cancer

Initial Patient Population:

All patients, regardless of age, with a diagnosis of prostate cancer

Denominator Statement:

Equals Initial Patient Population at low risk of recurrence receiving interstitial prostate brachytherapy, OR external beam radiotherapy to the prostate, OR radical prostatectomy, OR cryotherapy

Denominator Exclusions:

None

Numerator Statement:

Patients who did not have a bone scan performed at any time since diagnosis of prostate cancer

Numerator Exclusions:

Not Applicable

Denominator Exceptions:

Documentation of reason(s) for performing a bone scan (including documented pain, salvage therapy, other medical reasons, bone scan ordered by someone other than reporting physician)

Measure Steward: American Medical Association-convened Physician Consortium for Performance Improvement(R) (AMA-PCPI)
Domain: Efficiency and Cost Reduction Use of Healthcare Resources
Next Version: Prostate Cancer: Avoidance of Overuse of Bone Scan for Staging Low Risk Prostate Cancer Patients
Measure Score: Proportion
Score Type: Process
Improvement Notation:

Higher score indicates better quality

Guidance:

A higher score indicates appropriate treatment of patients with prostate cancer at low risk of recurrence.

Only patients with prostate cancer with low risk of recurrence will be counted in the performance denominator of this measure.

Specifications

External Resources